EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CB1 cannabinoid receptor agonists induce acute respiratory depression in awake mice

Joshua Watkins, Petra Aradi, Rachel Hahn, Alexandros Makriyannis, Ken Mackie, Istvan Katona, Andrea G Hohmann

Pharmacological Research · 2025

DOI: 10.1016/j.phrs.2025.107682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2025. Verfasst von Joshua Watkins und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological and Brain Sciences, Indiana University Bloomington, Bloomington, IN 47405, United States; Program in Neuroscience, Indian…. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, Respiratory Insufficiency, Dronabinol, Cannabinoid Receptor Agonists. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recreational use of synthetic cannabinoid agonists (i.e., "spice compounds") that target the cannabinoid type 1 receptor (CB1) can cause acute respiratory failure in humans. However, Δ9-tetrahydrocannabinol (Δ9-THC), the major psychoactive phytocannabinoid in cannabis, is not traditionally thought to interact with the brain respiratory system, based largely upon sparse labeling of CB1 receptors in the medulla and relative safety suggested by widespread human use. Here we used whole body plethysmography and RNAscope in situ hybridization in mice to reconcile this conflict between conventional wisdom and human data. We examined the respiratory effects of the synthetic CB1 full agonist CP55,940 and Δ9-THC in male and female mice. CP55,940 and Δ9-THC potently and dose-dependently suppressed minute ventilation and tidal volume, decreasing measures of respiratory effort (i.e., peak inspiratory and expiratory flow). Both cannabinoids reduced respiratory frequency, decreasing inspiratory and expiratory time while markedly increasing inspiratory and expiratory pause. Respiratory suppressive effects were fully blocked by the CB1 antagonist AM251, were minimally impacted by the peripherally-restricted CB1 antagonist AM6545, and occurred at doses lower than those that produce cardinal behavioral signs of CB1 activation. Using RNAscope in situ hybridization, we also demonstrated extensive coexpression of Cnr1 (encoding the CB1 receptor) and Oprm1 (encoding the µ-opioid receptor) mRNA in respiratory cells in the medullary pre-Bötzinger complex, a critical nucleus of respiratory control. Our results show that mRNA for CB1 is present in respiratory cells in a medullary brain region essential for breathing and demonstrate that cannabinoids produce respiratory suppression via activation of central CB1 receptors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB1Respiratory InsufficiencyDronabinolCannabinoid Receptor AgonistsCyclohexanolsAnimalsMaleFemaleMice, Inbred C57BLMiceRespirationReceptors, Opioid, muWakefulness

Stichwörter der Autor:innen

CannabinoidOpioidOverdosePre-Botzinger complexRespiratory depressionTHC

Substanzen

Receptor, Cannabinoid, CB1DronabinolCannabinoid Receptor Agonists3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanolCyclohexanolsReceptors, Opioid, mu

Autor:innen und Institutionen

  • Department of Psychological and Brain Sciences, Indiana University Bloomington, Bloomington, IN 47405, United States; Program in Neuroscience, Indiana University Bloomington, Bloomington, IN 47405, United States.
  • Department of Psychological and Brain Sciences, Indiana University Bloomington, Bloomington, IN 47405, United States.
  • Center for Drug Discovery, Northeastern University, Boston, MA 02115, United States.
  • Department of Psychological and Brain Sciences, Indiana University Bloomington, Bloomington, IN 47405, United States; Program in Neuroscience, Indiana University Bloomington, Bloomington, IN 47405, United States; Gill I…
  • Department of Psychological and Brain Sciences, Indiana University Bloomington, Bloomington, IN 47405, United States; Program in Neuroscience, Indiana University Bloomington, Bloomington, IN 47405, United States; Instit…

Förderung

  • NIDA NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Watkins, J., Aradi, P., Hahn, R., Makriyannis, A., Mackie, K., Katona, I., & Hohmann, A. G. (2025). CB1 cannabinoid receptor agonists induce acute respiratory depression in awake mice. Pharmacological Research. https://doi.org/10.1016/j.phrs.2025.107682

Vancouver

Watkins J, Aradi P, Hahn R, Makriyannis A, Mackie K, Katona I, et al. CB1 cannabinoid receptor agonists induce acute respiratory depression in awake mice. Pharmacological Research. 2025. doi:10.1016/j.phrs.2025.107682

BibTeX
@article{Watkins2025,
  author = {Watkins, Joshua and Aradi, Petra and Hahn, Rachel and Makriyannis, Alexandros and Mackie, Ken and Katona, Istvan and Hohmann, Andrea G},
  title = {CB1 cannabinoid receptor agonists induce acute respiratory depression in awake mice},
  journal = {Pharmacological Research},
  year = {2025},
  doi = {10.1016/j.phrs.2025.107682}
}
Kostenlos starten →